Fonti

Bleichmar Fonti & Auld LLP Files Lawsuit Against BioAge Labs Over Alleged IPO Misrepresentations, Urges Investors to Join Legal Action

by

NEW YORK — Legal actions have commenced against BioAge Labs, Inc., a clinical-stage biopharmaceutical company known for its advanced therapies aimed at metabolic diseases like obesity. A lawsuit filed in the U.S. District Court for the Northern District of California accuses BioAge and some of its top executives of potential breaches of federal securities laws. The securities law firm Bleichmar Fonti & Auld LLP, leading the litigations, announced these proceedings detailing that the lawsuit encapsulates claims under Sections 11 and 15 of the Securities Act of 1933. The complaint specifically represents investors who acquired shares … Read more

Lawsuit Filed Against Crocs, Inc. Over Alleged Securities Law Violations, Claims Bleichmar Fonti & Auld LLP

by

New York — Bleichmar Fonti & Auld LLP, a prominent securities law firm, has initiated a lawsuit against footwear manufacturer Crocs, Inc., along with several of its top executives, citing potential transgressions of federal securities laws. This legal action, rooted in alleged improper practices in supply chain management and sales reporting, was recently filed in the U.S. District Court for the District of Delaware, identified as Carretta v. Crocs, Inc., et al., No. 25-cv-00096. The complaint focuses on violations under the Securities Exchange Act of 1934, particularly Sections 10(b) and 20(a), representing investors who acquired … Read more